Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Biosimilars in IBD: hope or ex...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Biosimilars in IBD: hope or expectation?
Bibliographic Details
Main Authors:
Gecse, K
,
Khanna, R
,
van den Brink, G
,
Ponsioen, C
,
Löwenberg, M
,
Jairath, V
,
Travis, S
,
Sandborn, W
,
Feagan, BG
,
D'Haens, G
Format:
Journal article
Language:
English
Published:
2013
Holdings
Description
Similar Items
Staff View
Similar Items
Evolving concepts in phases I and II drug development for Crohn's Disease
by: Jairath, V, et al.
Published: (2016)
Hemolytic anemia after switching from infliximab originator to biosimilar CT‐P13 in a patient with inflammatory bowel disease: A case report
by: Anne S. Strik, et al.
Published: (2019-11-01)
Subcutaneous vedolizumab interval extension in inflammatory bowel disease patients: a case series
by: Suzanne I. Anjie, et al.
Published: (2024-02-01)
Evolving concepts in Phase I and II Drug Development for Crohn's Disease.
by: Jairath, V, et al.
Published: (2016)
Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's disease.
by: D'Haens, G, et al.
Published: (2009)